2025年
22.
Okada T, Natsumeda M, Fujiwara H, Higa N, Akahane T, Watabe Y, Tomikawa K, Nishida K, Tsukamoto Y, Ohshima S, Horii A, Tanimoto A, Hanaya R, Shimizu H, Kakita A, Oishi M. Improved hearing in a rare, adult IDH2-mutant brainstem astrocytoma successfully treated with radiation and temozolomide. Front Oncol, in press.
21.
Du S, Zhou Y, Li D, Lier J, Cella M, Tada M, Hamasaki H, Wu J, Cai Z, Orthmann-Murphy JL, Kakita A, Kipnis J, Bergner CG, Colonna M (epub 2025 Jun 26). Mutations in the human CSF1R gene impact microglia’s maintenance of brain white matter integrity. Nat Immunol, in press. doi: 10.1038/s41590-025-02195-7.
20.
Tsukamoto Y, Natsumeda M, Shimizu H, Takahashi H, Shibuma S, Takahashi A, Shida K, Fujiwara H, Nakayama Y, Saito R, Edda T, Okada M, Okamoto K, Kakita A, Oishi M (epub 2025 May 20). Rapidly progressive scalp and lung metastases with fatal pneumothorax in glioblastoma, IDH-wildtype, with MET and CDK6 amplifications: A case report of clinical course and postmortem autopsy, including genetic analysis. Brain Tumor Pathology 2025; doi: 10.1007/s10014-025-00503-5. in press.
19.
Sugita Y, Furuta T, Takahashi K, Higaki K, Koda Y, Mori S, Hongo S, Hamasaki H, Kakita A, Ueda M, Kitagawa K (epub 2025 May 26). Alzheimer’s disease with cardiac transthyretin amyloidosis: a clinicopathological study of autopsy cases. Neuropathology, in press. doi: 10.1111/neup.70011.
18.
Ozawa M, Saito R, Konno T, Kuroha Y, Ikeda T, Yokoseki A, Tani T, Tada M, Koide R, Fujimoto S, Onodera O, Kakita A (epub 2025 May 19). Late-onset multiple system atrophy: neuropathological features associated with slow disease progression. Brain Pathol 2025; e70016, in press. doi: 10.1111/bpa.70016.
17.
Kakita A, Kitaura H. Astrocyte alterations in epileptogenic brain lesions: a pathophysiological study. 臨床神経生理学 2025; 53 (2): , in press.
16.
Miyashita A, Obinata A, Hara N, Mitsumori R, Kaneda D, Hashizume Y, Sano T, Takao M, Gabdulkhaev R, Tada M, Kakita A, Arakawa A, Murayama S, Saito Y, Hatsuta H, Matsubara T, Akagi A, Riku Y, Miyahara H, Sone J, Iwasaki Y, Yoshida M, Yamaguchi H, Tsukie T, Hasegawa M, Kasuga K, Kikuchi M, Kuwano R, Iwatsubo T, Japanese Alzheimer’s Disease Neuroimaging Initiative, Niida S, Ozaki K, Ikeuchi T (epub 2025 May 21). Association of rare APOE missense variants with Alzheimer’s disease in the Japanese population. J Alzheimer Dis 2025: 133872877251340710, in press. doi: 10.1177/13872877251340710.
15.
柿田明美.脳・神経1(非腫瘍性).組織病理アトラス 第7版.大橋健一,伊藤智雄,牛久哲男,笹島ゆう子,田中伸哉,都築豊徳(編集)、文光堂,東京.pp. – . total pages. 2025年 月 日.in press.
14.
Miki Y, Shimoyama S, Tanaka MT, Kushibiki H, Nakahara A, Wen X, Hijioka M, Kon T, Murthy M, Furukawa T, Bettencourt C, Mori F, Mizukami H, Takahashi S, Tada M, KitamuraY, Kakita A, Warner TT, Wakabayashi K (2025 June 23). Abnormal a-synuclein binds to synaptotagmin 13, impairing extracellular vesicle release in synucleinopathies. Transl Neurodegener 2025; 14 (1): 32. Doi: 10.1186/s40035-025-00493-6.
13.
Kumagai S, Ogura R, Shibuya K, On J, Saito S, Sano M, Kakita A, Oishi M (2025 Jun 4). Syringomyelia associated with Magendie’s foramen obstruction due to probably congenital gliomesenchymal anomaly. NMC Case Rep J 2025; 12: 221-226. doi: 10.2176/jns-nmc.2025-0041.
12.
Gabdulkhaev R, Shimizu H, Kanazawa M, Kuroha Y, Hasegawa A, Idezuka J, Tainaka K, Onodera O, Kakita A (2025 Jun; epub 2024 Dec 12). Blood-brain barrier dysfunction in multiple system atrophy: a human postmortem study. Neuropathology 2025; 45 (3): 210-222. doi:10.1111/neup.13021.
11.
Miki Y, Inoue Y, Mori F, Tada M, Yoshida M, Lashley T, Warner TT, Kakita A, Wakabayashi K (2025 Jun). TAF15 and transportin 1 in intranuclear inclusions of neuronal intranuclear inclusion disease. Neuropathol Appl Neurobiol 2025; 51 (3): e70021. doi: 10.1111/nan.70021.
10.
Rahman SM, Tan C, Kakita A, Moruno-Manchon JF (2025 Apr-Jun; epub 2025 Apr 17). Sex differences in brain iron deposition and microglial ferritin in Alzheimer’s disease. Sci Prog 2025; 108 (2): 368504251336080. doi: 10.1177/00368504251336080.
9.
Nakajima A, Hokari M, Yanagimura F, Saji E, Shimizu H, Toyoshima Y, Yanagawa K, Arakawa M, Yokoseki A, Wakasugi T, Okamoto K, Watanabe K, Minato K, Otsu Y, Nozawa Y, Kobayashi D, Sanpei K, Kikuchi H, Hirohata S, Awamori K, Nawata A, Yamada M, Takahashi H, Nishizawa M, Igarashi H, Sato N, Kakita A, Onodera O, Kawachi I (2025 Apr 22; epub 2025 Mar 19). Long-term clinical landscape of spinal hypertrophic pachymeningitis with anti-neutrophil cytoplasmic antibody-associated vasculitis. Neurology 2025; 104 (8): e213420. doi: 10.1212/WNL.0000000000213420.
8.
Yamazaki R, Azuma M, Osanai Y, Kouki T, Inagaki T, Kakita A, Takao M, Ohno N (2025 Apr 13). Type I collagen secreted in white matter lesions inhibits remyelination and functional recovery. Cell Death Dis 2025; 16 (1): 285. doi: 10.1038/s41419-025-07633-w.
7.
Ito Y, Fukuda M, Ono K, Ota T, Watanabe M, Matsuda T, Hatakeyama K, Masuda H, Kitaura H, Kakita A, Oishi M, Igarashi H (2025 Apr 4). Visualizing epileptogenic regions using the chemical exchange saturation transfer method in a patient with drug-resistant focal epilepsy. J Med Case Rep 2025; 19 (1): 158. doi: 10.1186/s13256-025-05191-5.
6.
Shibuma S, On J, Natsumeda M, Koyama A, Takahashi H, Watanabe J, Mitobe M, Nakata S, Tanaka Y, Tsukamoto Y, Okada M, Yoshimura J, Tada M, Shimizu H, Oya S, Murai J, Okamoto K, Kawashima H, Kakita A, Oishi M (2025 Apr; epub 2025 Jan 9). Diagnosis of leptomeningeal disease in diffuse midline gliomas by detection of H3F3A K27M mutation in circulating tumor DNA of cerebrospinal fluid. Pediatr Blood Cancer 2025; 72 (4): e31535. doi: 10.1002/pbc.31535.
5.
Ando S, Saito R, Kitahara S, Uemura M, Hatano Y, Watanabe M, Kato T, Ito Y, Nalini A, Ishihara T, Murayama S, Igarashi H, Kakita A, Onodera O (2025 Feb 26). “Chocolate chip sign” on susceptibility-weighted imaging: a novel neuroimaging biomarker for HTRA1-related cerebral small vessel disease. Neurol Genet 2025; 11 (2): e200237. doi:10.1212/NXG.0000000000200237.
4.
Hongo S, Ikeda T, Tada M, Aida R, Ozawa T, Lixin L, Hara N, Miyashita A, Nakajima T, Ichinose H, Ikeuchi T, Onodera O, Kakita A (2025 Feb). Clinicopathologic and biochemical features of an autopsied patient with hereditary spastic paraplegia carrying a GTP cyclohydrolase 1 mutation. Neuropathol Appl Neurobiol 2025; 51 (1): e70006. doi: 10.1111/nan.70006.
3.
Iida M, Tanaka M, Takagi T, Matsuki T, Kimura K, Shibata K, Kobayashi Y, Mizutani Y, Kuwamura H, Yamada K, Kitaura H, Kakita A, Sakakibara M, Asai N, Takahashi M, Asai M (2025 Feb; epub 2024 Dec 15). Girdin deficiency causes developmental and epileptic encephalopathy with hippocampal sclerosis and interneuronopathy. Epilepsia 2025; 66 (2): 599-617. doi: 10.1111/epi.18204.
2.
Hongo S, Shimizu H, Saji E, Nakajima A, Okamoto K, Kawachi I, Onodera O, Kakita A (2025 Feb 2; Epub 2024 Apr 7). Acute respiratory failure caused by brainstem demyelinating lesions in an older patient with an atypical relapsing autoimmune disorder. Neuropathology 2025; 45 (1): 3-12. doi: 10.1111/neup.12976.
1.
Saito Y, Sugai K, Iwasaki M, Sato N, Kakita A, Saito Y, Ohtsuki T, Sasaki M (2025 Jan; epub 2024 Nov 27). Surgical outcome and contributing presurgical evaluations in children with magnetic resonance imaging-negative epilepsy and periodic seizure cycles. Epilepsy Res 2025; 209: 107492. doi: 10.1016/j.eplepsyres.2024.107492.